Page 126 - Read Online
P. 126

Ibrahim et al                                                                                                                                                                                        ALDHs and prostate cancer

           reductions in proliferation rate and the invasive ability   ALDH1A3 has been demonstrated to be an androgen
           of PC-3 cells. However, the regulation of ALDH1A3   responsive gene [67]  whose induction contributes
           expression is likely to be multifactorial [87] .   to the conversion of retinol to RA with potential for
                                                              supporting cellular proliferation [55] . Hypermethylation
           Outside the ALDH1 family, strong association of    of the ALDH1A3 promoter region in clinical tissues
           ALDH3A1 with PCa progression has also been         has also been detected [99] , but this study used a
           demonstrated in both immortalised cancer cell      relatively small sample size (n = 24) and did not
           lines and tumour xenografts [61] . In clinical tissues   distinguish between methylation of basal and luminal
           ALDH3A1 was detected in intra-epithelial neoplasia,   PCa cells. Although larger studies are required, it is
           with elevated levels in carcinomas in the absence   possible that methylation of the promoter regions of
           of expression in normal prostate glands. Finally,   ALDH1A2 and ALDH1A3 could be used as a marker
           in comparison with the paired local carcinomas,    for PCa detection [55] .
           ALDH3A1 was upregulated in both lymph node
           metastatic tumours and was detectable in bone      ALDH EXPRESSION IN CSC
           metastatic PCa.                                    MICROENVIRONMENT

           ALDH7A1, which has also been related to the
           stemness of CSCs   [88] , is mainly localised in the   Growing evidence strongly supports initiation of PCa
                                                                                                     [100-105]
           cytosol, but it has also been found expressed to a   from CSCs residing within a basal niche    . In
           lesser degree in the mitochondria and nucleus [32,45] .   xenotransplantation experiments, less than 100 TICs
           In addition to catalysing aldehyde metabolism,     are needed to generate a new tumour in mice and
                                                                                              [106]
           ALDH7A1 also plays a role in protecting tissues from   these cells exhibit a basal phenotype  . Furthermore,
           the damaging effects of osmotic stress  while mutation   using human tissue biopsies the prostate SC markers
                                            [89]
           of the ALDH7A1 gene has been related to pyridoxine-  CD44+, α2β1-integrinhigh and CD133+ have been
           dependent epilepsy  [90,91] . In cancer, ALDH7A1 is   used to identify and isolate prostate CSCs with self-
                                                                                     [100]
           expressed in nodular melanoma (NM) [92] , ovarian [93]    renewal capacity in vitro  . Additionally, there are
           and lung cancers [94]  while in PCa the isoform has   other important markers that have been used to
           been shown to be involved in intra-bone growth and   identify and isolate PCa SCs. ATP binding cassette
           induced bone metastasis [64]  as well as zoledronic   (ABC) transporters which are proteins that play a
           acid  resistance [95] .  Gene  expression  profiling   vital role in the efflux of drugs have also been used
           supports the involvement of ALDH7A1 in multiple    to enrich CSCs. However, CD44+, α2β1-integrin high
           molecular pathways related to the metastatic process   and CD133+ ABC transporters are also expressed
                                                                           [107,108]
           in PCa [96] .                                      in normal SCs       which emphasises the need to
                                                              employ at least two markers to avoid cross reacting
                                                              populations of cells [107] . A growing body of evidence
           EVIDENCE FOR EPIGENETIC CONTROL OF                 suggests that the functional activity of ALDHs can be
           ALDHS                                              used to identify and purify CSCs from e.g. breast [109] ,
                                                              ovary [110] , lung [111] , colon [112] , pancreas [113]  and
           PCa can  be initiated  by genetic or epigenetic    prostate cancer [114] . At present it is unclear if ALDH
           alterations, including DNA methylation in the      expression is significantly different between normal
           promoter region of genes, normally linked to       SCs and CSCs, hence more research is required to
           transcriptional silencing [55] . Epigenetic changes   understand if any isoforms could be more predictive
           including DNA methylation and histone modifications   than e.g. CD44+, α2β1-integrin high and CD133+
           of tumour suppressor genes (TSGs) preferentially   used as a PCa SC gene-expression signature [115] .
           occur in the early stages of cancer progression [55] .
           The promoter region of ALDH1A2 in primary          ALDHs expressed in SCs are members of the ALDH1
           PCa specimens has been shown to be densely         family (1A1, 1A2, 1A3, 1L1, 1L2), ALDH2, ALDH3A1,
           hypermethylated in comparison to normal prostate   ALDH4A1 and ALDH7A1, which have all been linked
           tissues [97] . This observation is supported by another   with various critical roles including chemo-protection,
           study  that  showed  a  low/absent  expression of   DNA damage and regulation of the cell cycle [24] .
           ALDH1A2 in PCa in formalin-fixed paraffin embedded   The Aldefluor assay has frequently been used to
           sections compared to elevated levels of expression   identify and isolate CSCs, but as this assay does not
           in normal prostate tissue [98] . On this basis it was   distinguish between different isoforms many studies
           suggested that ALDH1A2 act as a TSG in PCa,        suffer from a lack of knowledge of the contributing
           and that its epigenetic regulation could differentiate   ALDHs to the stemness of the isolated subpopulations
           normal prostate cells from malignancy. In contrast,   with tumourigenic properties. However, some
             4                                                                      Journal of Cancer Metastasis and Treatment ¦ Volume 4 ¦ Aug 21, 2018
   121   122   123   124   125   126   127   128   129   130   131